<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03512535</url>
  </required_header>
  <id_info>
    <org_study_id>31426</org_study_id>
    <nct_id>NCT03512535</nct_id>
  </id_info>
  <brief_title>Method Validation for New Nitrogen/Sulfur Species Analysis Techniques</brief_title>
  <official_title>Method Validation for New Nitrogen/Sulfur Species Analysis Techniques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southampton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Southampton</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Plasma redox status is well known to alter with age but previously differences have only been&#xD;
      reported for two specific redox couples; reduced and oxidized cysteine and reduced and&#xD;
      oxidized glutathione. (Jones DP, Rejuvenation Res. 2006) The overall aim of this project is&#xD;
      to develop new methods to determine how other Reactive Nitrogen and Sulfur species, such as&#xD;
      free and protein-bound thiols (organic compounds that contain a Sulfhydryl group, -SH) and&#xD;
      Hydrogen Sulfide (H2S) change with age and gender in a medium-sized cohort of healthy&#xD;
      individuals (n=100 of either sex; age 18-70).&#xD;
&#xD;
      Our group has recently developed a novel analytical platform to measure thiol-containing&#xD;
      compounds in biological samples that is based on the reaction with the thiol-alkylating agent&#xD;
      N-ethylmaleimide (NEM). We have used this chemical for years as stabilisation agent in other&#xD;
      analyses to quantify Nitric Oxide metabolites.(Feelisch et al, FASEB 2002 and Levett et al,&#xD;
      Sci Rep 2011) We now wish to develop a similar method to measure thiol containing compounds&#xD;
      using a novel rapid LC-MS/MS based technology for screening large numbers of individuals.&#xD;
&#xD;
      The project will therefore have 2 stages:&#xD;
&#xD;
        1. Initial method development will require occasional use of whole blood, plasma and red&#xD;
           blood cells to establishing optimal conditions. E.g. to compare heparin and EDTA as&#xD;
           anticoagulants to serum; investigate effects of temperature and pH; identify optimal&#xD;
           concentration of derivatisation/reduction agents and optimal reaction times.&#xD;
&#xD;
        2. We then aim to establish the normal distribution of these novel compounds across healthy&#xD;
           individuals of different gender and varying ages.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 29, 2018</start_date>
  <completion_date type="Anticipated">November 2024</completion_date>
  <primary_completion_date type="Anticipated">November 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Concentration of reactive (nitrogen or sulfur containing) species</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Redox Status</condition>
  <arm_group>
    <arm_group_label>Stage 1</arm_group_label>
    <description>Samples from up to 20 participants will be used to finalise the analytical methods</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stage 2</arm_group_label>
    <description>Samples from up to 200 participants will be used to then validate the normal ranges of these markers across different age ranges in both genders</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma, serum and whole blood pellets&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy adult volunteers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 18 years or above&#xD;
&#xD;
          -  Currently healthy (i.e. no inter-current illness/infection)&#xD;
&#xD;
          -  Capacity and ability to give written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current or previous smoker&#xD;
&#xD;
          -  Other medical co-morbidity (e.g. hypertension, diabetes, asthma, COPD, cardiovascular&#xD;
             disease, current or previous malignant disease etc.)&#xD;
&#xD;
          -  Surgery within previous 28 days&#xD;
&#xD;
          -  Excessive alcohol intake (i.e above UK's recommended intake limit of 14 units per&#xD;
             week).&#xD;
&#xD;
          -  Pregnant or currently breast-feeding&#xD;
&#xD;
          -  On current medication&#xD;
&#xD;
          -  Taken vitamins / minerals / herbal remedies within previous 28 days&#xD;
&#xD;
          -  Difficult venous access&#xD;
&#xD;
          -  Needle phobia&#xD;
&#xD;
          -  Participating in another similar/conflicting research study already&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Martin Feelisch, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Southampton</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Southampton</name>
      <address>
        <city>Southampton</city>
        <state>Hampshire</state>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 18, 2018</study_first_submitted>
  <study_first_submitted_qc>April 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2018</study_first_posted>
  <last_update_submitted>March 19, 2021</last_update_submitted>
  <last_update_submitted_qc>March 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

